Amplo Biotechnology
Pompano Beach, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JK
Jean KimNamed on SEC filing
PH
Paul HawkinsNamed on SEC filing
TV
Terry VanceNamed on SEC filing
MP
Matthew PaulsNamed on SEC filing
PS
Patricio SepulvedainNamed on SEC filing
Board
DB
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2021
▶$2.2MraisedOct 2021 · 15 investors · BiotechnologyRule 506(b)
▶$2.2MraisedOct 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean KimDirector
- Paul HawkinsExecutive Officer, Director
- Terry VanceDirector
- Daniel BradburyDirector
- Matthew PaulsDirector
- Patricio SepulvedaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapBioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Aro Biotherapeutics8 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Cerecor Inc.8 shared keywordsAvalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
Applied Therapeutics7 shared keywordsApplied Therapeutics is a biopharmaceutical company developing treatments for rare diseases, with a portfolio focused on Classical Galactosemia and CMT-SORD. Its lead investigational drug, govorestat, targets disease pathways such as galactitol and sorbitol reduction.
Artelo Biosciences6 shared keywordsArtelo Biosciences is a clinical-stage biopharmaceutical company developing therapeutics that modulate lipid-signaling pathways, with a pipeline of drug candidates aimed at treating cancer and related conditions.
Arpelos6 shared keywordsArpelos Biosciences is a seed-stage biotech company developing multivalent targeted therapeutics aimed at high potency and selectivity, drawing on compute, immunology, and protein engineering. It is based in Kendall Square (Cambridge, Massachusetts).
Companies competing with Amplo Biotechnology for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Amplo Biotechnology's investors?
- Amplo Biotechnology's investors include BioBrit.
- How much funding has Amplo Biotechnology raised?
- Amplo Biotechnology has disclosed $2.2M raised across 1 round.
- Where is Amplo Biotechnology headquartered?
- Amplo Biotechnology is headquartered in Pompano Beach, US.